Natraceutical and Laboratorio Reig Jofre join the consolidation process of the European pharmaceutical industry

The new company resulting from the merger will strengthen its position in the pharmaceutical market by means of the synergies in research and development of new products, regulatory knowledge, own production and combined access to more than 60 countries in 5 continents.

According to 2013 results, after this merger Natraceutical will multiply its turnover by almost five times, up to 149.7 M€, thus becoming the fifth Spanish pharma company by turnover quoted in Spain, with combined EBITDA of 16.1 M€.

The companies expect to close 2014 with combined organic growth of 5.6% in sales and 21.0% in EBITDA.

Download the full document (PDF)

Download the presentation (PDF)